Contact
Please use this form to send email to PR contact of this press release:
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
TO:
Please use this form to send email to PR contact of this press release:
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
TO: